GOLDMAN SACHS GROUP INC - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$81,309
+21.8%
88,054
+0.1%
0.00%
Q1 2023$66,737
-69.8%
87,985
-0.0%
0.00%
Q4 2022$220,875
+81.0%
87,9980.0%0.00%
Q3 2022$122,000
+3.4%
87,998
-5.8%
0.00%
Q2 2022$118,000
-57.2%
93,381
-1.9%
0.00%
Q1 2022$276,000
+27.2%
95,233
-0.1%
0.00%
Q4 2021$217,000
-11.1%
95,343
+0.0%
0.00%
Q3 2021$244,000
-10.6%
95,3420.0%0.00%
Q2 2021$273,000
-8.1%
95,3420.0%0.00%
Q1 2021$297,000
+18.8%
95,3420.0%0.00%
Q4 2020$250,000
+127.3%
95,342
+149.4%
0.00%
Q3 2020$110,000
-20.3%
38,223
-5.2%
0.00%
Q2 2020$138,000
+43.8%
40,312
-16.1%
0.00%
Q1 2020$96,000
-52.9%
48,073
-5.7%
0.00%
Q4 2019$204,000
-37.4%
50,982
-50.1%
0.00%
Q3 2019$326,000
-7.4%
102,244
+13.3%
0.00%
Q2 2019$352,000
-68.3%
90,204
+97.4%
0.00%
Q1 2019$1,110,000
+187.6%
45,686
+137.9%
0.00%
Q4 2018$386,00019,2040.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Nantahala Capital Management 1,136,416$1,049,3670.10%
Anson Funds Management LP 129,795$119,8530.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$550.01%
Hudson Bay Capital Management LP 274,300$253,2890.00%
UBS Group AG 33$300.00%
RHUMBLINE ADVISERS 347$3200.00%
OSAIC HOLDINGS, INC. 200$1840.00%
WELLS FARGO & COMPANY/MN 132$1220.00%
NORTHERN TRUST CORP 22,231$20,5280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACER THERAPEUTICS INC shareholders